Advertisement
Advertisement
Michael Yu Dechao, chairman and co-founder of Innovent Biologics. Photo: Edmond So
Hong Kong listed Innovent Biologics believes it can help usher in a ‘game changer’ for drug prices in China
- Innovent Biologics, one of the first batch of firms listed in Hong Kong under the new listing regime, jumped 18.6 per cent to close at HK$16.58 in debut trade on Wednesday
Topic |
Pharmaceuticals
Updated: 7:00am, 1 Nov, 2018
Advertisement
TOP PICKS
Michael Yu Dechao, chairman and co-founder of Innovent Biologics. Photo: Edmond So
READ FULL ARTICLE
Advertisement
Advertisement
SCMP TODAY: INTL EDITION
Get updates direct to your inbox
By registering, you agree to our T&C and Privacy Policy
Thank you for your subscription.
You can also view our other newsletters.
Products & Services
Our Sites
DOWNLOAD THE SCMP APP
Copyright © 2019 South China Morning Post Publishers Ltd. All rights reserved.